(firstQuint)The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines.

 Hepatitis A refers to liver inflammation caused by infection with the hepatitis A virus.

 HAV is is one of the most common hepatitis viruses that can cause hepatitis in China.

 The data from the phase 1, 2 and 3 trials suggested that both inactivated hepatitis A vaccine and live attenuated hepatitis A vaccine had a clinically acceptable safety and good immunogenicity for healthy Chinese people.

.

 The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines@highlight

The purpose of this Phase 4 trial is to assess the safety, immunogenicity, three-year immune persistence of inactivated hepatitis A vaccine (HAV) and live attenuated HAV vaccine.

